Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis

Collier, Dami; Iwuji, Collins; Derache, Anne; de Oliveira, Tulio; Okesola, Nonhlanhla; Calmy, Alexandra; Dabis, Francois; Pillay, Deenan; Gupta, Ravindra K.

doi:10.1093/cid/cix015

Scientific article

French

Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis

ContributorsCollier, Dami; Iwuji, Collins; Derache, Anne; de Oliveira, Tulio; Okesola, Nonhlanhla; Calmy, Alexandra

; Dabis, Francois; Pillay, Deenan; Gupta, Ravindra K.

Published inClinical Infectious Diseases, vol. 64, no. 8, p. 1006-1016

Publication date2017

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

VIH/SIDA (930)

Citation (ISO format)

COLLIER, Dami et al. Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis. In: Clinical Infectious Diseases, 2017, vol. 64, n° 8, p. 1006–1016. doi: 10.1093/cid/cix015

Article (Published version)

Identifiers

PID : unige:112375
DOI : 10.1093/cid/cix015
PMID : 28329393

Journal ISSN1058-4838

412views

200downloads

Creation06/11/2018 16:51:00

First validation06/11/2018 16:51:00

Update time15/03/2023 15:16:55

Status update15/03/2023 15:16:54

Last indexation31/10/2024 12:17:11

Archive ouverte UNIGE

Virological Outcomes of Second-line Protease Inhibitor–Based Treatment for Human Immunodeficiency Virus Type 1 in a High-Prevalence Rural South African Setting: A Competing-Risks Prospective Cohort Analysis

Technical informations